Valvular Heart Disease – 2025 ESC/EACTS Guidelines
Valvular Heart Disease – 2025 ESC/EACTS Guidelines
• TAVR: Expanded role, not only for elderly but also selected younger/high-risk patients.
• Minimally invasive mitral valve surgery (MIMVS):
• Via mini-thoracotomy or right mini-sternotomy instead of full sternotomy.
• Benefits: less pain, bleeding, shorter stay, faster recovery, better cosmesis.
• Safe and effective in experienced centers, especially for degenerative mitral regurgitation.
• May extend to tricuspid and combined valve disease in high-volume centers.
• Requires Heart Team evaluation and advanced imaging (3D echo, CT, CMR).
• Advanced imaging:
• 3D echo for valve anatomy/quantification.
• CT for TAVR planning, annular sizing, coronary distance.
• CMR for ventricular volumes, regurgitant quantification when echo inconclusive.
• Referral: Complex cases should go to high-volume expert centers.
• Clinical implication: Technology-driven, patient-centered, less invasive interventions.
